AI’s Role in Global Health Policy Explored in New Research

By Sumona Bose

January 9, 2024

Introduction

Artificial intelligence (AI) has the potential to transform global health policy, according to a recent study published in the Journal of Health Policy and Planning. The research highlights the various ways in which AI can contribute to inclusive healthcare practices and ethical access, while also identifying areas for improvement. The study emphasizes that AI has primarily been used in delivering public services rather than policymaking. However, the researchers argue that AI can play a crucial role in shaping global health policy by providing valuable insights and analysis. By harnessing the power of big data and AI, policymakers can assess the potential outcomes of their interventions and make more informed decisions.

AI’s Potential in Global Health

One of the key benefits of AI in health policy is its ability to analyze heterogeneous data from various sources, including healthcare devices, clinical records, and environmental data. This comprehensive analysis can help policymakers understand the complex factors that influence public health, such as access to healthcare, socioeconomic conditions, and information systems.The researchers also highlight the importance of considering multiple dimensions when developing policy options. They suggest that future studies should provide policymakers with real-time learning opportunities, address pandemics, and prevent non-communicable diseases. By tracking key performance indicators like mortality, morbidity, and life expectancy, policymakers can make evidence-based decisions that improve overall health outcomes.

Figure 1: A Framework for Interactions between AI and the elements of health policy triangle.

AI’s Contribution to Global Health Policy

Furthermore, the study emphasizes the need for transparency and accountability in policymaking. AI can help policymakers consider factors like public preferences, societal voices, and institutional transparency when developing policies. This ensures that policies are aligned with the needs and values of the population, ultimately improving life expectancy, quality of life, and social well-being.The researchers also highlight specific areas where AI can enhance global health policy. For example, AI can improve situational awareness by identifying the causes of policy failure and providing early crisis warnings. It can also reduce decision-making bias by exploring the social context and improving communication effectiveness. Additionally, AI applications like geographic information systems (GIS) can integrate and analyze geospatial data, enabling better disease surveillance and prevention.

Figure 2: A Framework for AI-equipped policymaking: existing knowledge and future directions

Conclusion

The study concludes by emphasizing that AI has the potential to reconfigure the policy process by enabling new methods of data collection, analysis, and decision-making. By equipping health systems with AI capabilities, policymakers can make more informed decisions and achieve progressive goals.Overall, this research highlights the significant role that AI can play in shaping global health policy. By leveraging AI’s capabilities, policymakers can improve healthcare access, address inequalities, and make evidence-based decisions that benefit global healthcare.

Reference url

Recent Posts

Weight Loss: Advances in Hormone-Based Obesity Treatments

By HEOR Staff Writer

November 12, 2025

Advances in Hormone-Based Pharmacotherapies for Obesity Hormone-based obesity treatments are improving the approach to weight management by targeting the body's neurometabolic systems. A recent
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
NICE's Unified Prioritization Roadmap NICE NHS prioritization has led to a new, unified framework and board that will tackle emerging healthcare innovations while managing finite assessment capacity. The approach focuses on high-impact areas, including mental health, early cancer detect...
CTX310 Lipid Disorder: Phase 1 Trial Shows Promising LDL and Triglyceride Reductions

By HEOR Staff Writer

November 10, 2025

CTX310 Breakthrough in Lipid Disorder Treatment CTX310 is a significant advancement as the first-in-human Phase 1 trial of this CRISPR-Cas9 gene-editing therapy...